The FDA’s new Expedited IND Pilot will cut unnecessary delays in early-stage clinical research without compromising patient safety.
The FDA’s new Expedited IND Pilot will cut unnecessary delays in early-stage clinical research without compromising patient safety.
No comments yet. Be the first to share your thoughts.